ℹ️ Compiled from public regulatory records · Last regulator revision: January 9, 2026🚩 Report this page
Sodium Tetradecyl Sulfate
Sclerosing Agents For Local Injection
Sold as TROMBOJECT 3% · TROMBOJECT 1%
CA Health Canada
- Drug class
- Sclerosing Agents For Local Injection
- Availability
- See label
- Routes
- Intravenous
- Markets covered
- 1
- Products on record
- 2
Overview
Sodium Tetradecyl Sulfate is an active pharmaceutical ingredient in the Sclerosing Agents For Local Injection group (C05BB). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| CA Canada | Health Canada | 2 | January 9, 2026 |
CACanada· Health Canada
2 products
2 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [1].
Brands in Canada (2)
Sources & citations
- [1]Health Canada (DPD) · 00511226 · revised January 9, 2026
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.